#ObesityCare #GLP1 #Wegovy #NovoNordisk #OralGLP1 #MetabolicHealth #CardiovascularRisk #CompetitiveIntelligence #Phenomiqs To view or add a comment, sign in Eli Lilly on Thursday said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials on the weekly injection
GLP-1 medications are a class of drugs initially developed for type 2 diabetes that have demonstrated significant weight loss benefits
For those with sensitive skin or higher susceptibility to pigmentation issues, low-level laser therapy (LLLT) can be a gentler melanin reduction treatment option for hyperpigmentation
safety concerns) The timeline for potential FDA approval depends on Phase 3 trial results, which are expected to read out over the next one to two years
doi: 10.3390/nu13113965 139 YangY.ZhongZ.WangB.XiaX.YaoW.HuangL.et al
Powered by glutathione, this firming body lotion helps reduce visible dullness and keeps the skin feeling fresh and revitalized.Formulated with glycerol and niacinamide, it works to restore moisture, help refine skin texture, and leave the skin feeling soft, balanced, and comfortable